KEEGAN RUSSELL: Open Payments
NPI 1073034914 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,176 in 200 payments from 48 companies in 2025. Trend: 2023 $6,367 · 2024 $5,059 · 2025 $9,176
Food & beverage: $4,973Speaker / faculty: $3,000Honoraria: $700Travel & lodging: $412Education: $91
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $3,828 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $777 |
| AstraZeneca Pharmaceuticals LP | 22 | $753 |
| Daiichi Sankyo Inc. | 11 | $352 |
| PFIZER INC. | 13 | $296 |
| Merck Sharp & Dohme LLC | 11 | $283 |
| Janssen Biotech, Inc. | 7 | $224 |
| E.R. Squibb & Sons, L.L.C. | 11 | $216 |
| Novartis Pharmaceuticals Corporation | 9 | $162 |
| ARRAY BIOPHARMA INC | 9 | $152 |
Products named: VENCLEXTA, FIRDAPSE, IMFINZI, KEYTRUDA, DATROWAY, TECVAYLI, OPDIVO, FOTIVDA.
Industry payments across AZ — which companies pay providers there.
